Most importantly, the prevalence of established risk factors for advanced fibrosis or accelerated fibrosis progression (such as prior alcohol abuse, HCV-GT3, low CD4+ nadir, etc.)was comparable between patients with and without PNPLA3 risk alleles. This evidence concerns the gene PNPLA3 and alcohol abuse.